Filing Details

---

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13D/A

Under the Securities Exchange Act of 1934

(Amendment No. 3)*

 

 

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box ☐.

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent.

^* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

---

 

 

  (1) Based upon 36,781,989 shares of Common Stock, par value $0.01 per share ("Common Stock") of the Issuer (as defined below) outstanding as of December 31, 2023, as reported in the Issuer's Quarterly Report on Form 10-Q for the period ended December 31, 2023 filed with the Securities and Exchange Commission (the "Commission") on February 5, 2024.

Item 1.  Security and Issuer.

This Amendment No. 3 to Schedule 13D ("Schedule 13D/A") relates to shares of Common Stock of NAPCO Security Technologies, Inc. (the "Issuer"), whose principal executive offices are located at 333 Bayview Avenue, Amityville, NY  11701.

Item 2.  Identity and Background.

a.	This Schedule 13D/A is being filed by Richard Soloway (the "Reporting Person").

b.	The business/residence address for the Reporting Person is 333 Bayview Avenue, Amityville, NY  11701.

c.	The present principal occupation of the Reporting Person is Chairman of the Board, President and Chief Executive Officer of the Issuer.

d.	During the last five years, the Reporting Person has not been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).

e.

During the last five years, the Reporting Person has not been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, Federal or state securities laws or finding any violation with respect to such laws.

f.	The Reporting Person is a citizen of the United States.

Item 3.  Source or Amount of Funds or Other Consideration.

Not applicable.

Item 4.  Purpose of Transaction.

On March 5, 2024, the Reporting Person entered into an Underwriting Agreement (the “Underwriting Agreement”) with the Issuer and Needham & Company, LLC, Cowen and Company, LLC and D.A. Davidson and Co., as underwriters (the “Underwriters”), pursuant to which the Underwriters purchased from the Reporting Person 2,000,000 shares of Common Stock at a price of $39.73125 per share (the “Firm Shares”), in connection with a registered public secondary offering (the “Secondary Offering”) of the Shares at a public offering price of $40.75 per share. The sale of Firm Shares closed on March 8, 2024. In addition, the Reporting Person granted the Underwriters an option to purchase up to 300,000 additional shares of his Common Stock at the same price, exercisable by the Underwriters at any time and from time to time during the 30-day period from March 5, 2024. The foregoing description of the Underwriting Agreement does not purport to be complete and is qualified in its entirety by reference to such agreement, which is incorporated by reference as Exhibit 1 hereto and is incorporated herein by reference.

 

Except as set forth above, including, without limitation, the Secondary Offering, the Reporting Person has no present plans or proposals which would result in or relate to any of the transactions described in subparagraphs (a) through (j) of Item 4 of Schedule 13D.

Item 5.  Interest in Securities of the Issuer.

(a)-(b) As of the date hereof, the Reporting Person may be deemed to be the beneficial owner of 1,770,010 shares of Common Stock, representing approximately 4.8% of the Issuer's issued and outstanding shares of Common Stock, based upon 36,781,989 shares of Common Stock outstanding as of December 31, 2023, as reported in the Issuer's Quarterly Report on Form 10-Q for the period ended December 31, 2023 filed with the Commission on February 5, 2024.  The Reporting Person has sole power to vote, or direct the voting of, and to dispose of, or direct the disposition of, an aggregate of 1,770,010 shares of Common Stock.

(c)  Except as described in this Schedule 13D/A and below, there have been no transactions in the shares of Common Stock effected by the Reporting Person during the past 60 days.  On February 9, 2024, the Reporting Person exercised options granted by the Issuer for the purchase of an aggregate of 38,000 shares of Common Stock.  The exercise prices were $4.813 with respect to 6,000 shares, $8.08 with respect to 16,000 shares and $16.795 with respect to 16,000 shares.  In addition, on February 14, 2024, the Reporting Person sold 28,000 shares of Common Stock in open market transactions at a weighted average price of $45.12 per share.  The actual selling prices ranged from $45.00 to $45.32 per share.

(d)  None

(e)  On March 8, 2024, the Reporting Person ceased to be the beneficial owner of more than 5% of the outstanding shares of Common Stock.

 

 

Item 6.  Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.

Item 7.  Material to Be Filed as Exhibits.

 

Exhibit Number	Description of Exhibit
1	Underwriting Agreement, dated as of March 5, 2024, by and among the Issuer, the Reporting Person and the Underwriters (incorporated by reference to Exhibit 1.1 to Form 8-K filed on March 7, 2024).
2	Lock-up Agreement, dated as of March 5, 2024, executed by the Reporting Person.

 

 

 

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: March 12, 2024

 

 

 

Exhibit 2